Systemic Embolic Events (SEE) in Atrial Fibrillation SEEing Embolic Risk More Clearly

被引：6
|
作者：
Chatterjee, Neal A. [1 ]
Lubitz, Steven A. [1 ,2 ]
机构：
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA USA
来源：
CIRCULATION | 2015年 / 132卷 / 09期
基金：
美国国家卫生研究院;
关键词：
Editorials; arrhythmias; cardiac; atrial fibrillation; atrial flutter; embolism; THROMBOEMBOLISM; STROKE; CLOPIDOGREL; ASPIRIN;
D O I：
10.1161/CIRCULATIONAHA.115.018172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：787 / 789
页数：3
相关论文
共 50 条
  • [21] Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation
    Stöllberger, C
    Chnupa, P
    Kronik, G
    Brainin, M
    Finsterer, J
    Schneider, B
    Slany, J
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) : 630 - +
  • [22] Ximelagatran is noninferior of warfarin for prevention of strokes and systemic embolic events in patients with atrial fibrillation: SPORTIF V results
    Trifonov, IP
    KARDIOLOGIYA, 2004, 44 (01) : 73 - 74
  • [23] Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
    Echeverria, L. E.
    Sanchez-Garcia, R.
    Mantilla, A. F.
    Pizarro, M. P.
    Jimenez, O.
    Rojas, L. Z.
    Gomez-Ochoa, S. A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [24] Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
    Echeverria, L. E.
    Sanchez-Garcia, R.
    Mantilla, A. F.
    Pizarro, M. P.
    Jimenez, O.
    Rojas, L. Z.
    Gomez-Ochoa, S. A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?
    Reiffel, JA
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (01) : 58 - 63
  • [26] Percutaneous Closure of Left Atrial Appendage to Prevent Embolic Events in High-Risk Patients With Chronic Atrial Fibrillation
    Ussia, Gian Paolo
    Mule, Massimiliano
    Cammalleri, Valeria
    Scarabelli, Marilena
    Barbanti, Marco
    Imme, Sebastiano
    Mangiafico, Sarah
    Marchese, Anna
    Galassi, Alfredo Ruggero
    Tamburino, Corrado
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 74 (02) : 217 - 222
  • [27] The conundrum of ALI and systemic embolic events: SEEing our way to improved vascular health
    Hirsch, Alan T.
    Van't Hof, Jeremy R.
    Bonaca, Marc
    VASCULAR MEDICINE, 2016, 21 (06) : 535 - 538
  • [28] Multiple embolic events and ruption of the central venous catheter in a patient with atrial fibrillation
    Ostrowski, Tomasz
    Semczuk-Kaczmarek, Karolina
    Maciag, Rafal
    Platek, Anna E.
    Galazka, Zbigniew
    Szymanski, Filip M.
    CARDIOLOGY JOURNAL, 2021, 28 (02) : 349 - 350
  • [29] Relation of Left Atrial Enlargement to Subsequent Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients With Low to Borderline Embolic Risk
    Cho, Min Soo
    Choi, Kee-Joon
    Kim, Minsoo
    Do, Ungjeong
    Kim, Jun
    Nam, Gi-Byoung
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 143 : 67 - 73
  • [30] Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Marchan, Alvaro
    Fernandez-Sanz, Tamara
    Barreiro-Pardal, Cristina
    Pousa, Isabel Munoz
    Erquicia, Pablo Dominguez
    Ledo-Pineiro, Ana
    Gonzalez-Bermudez, Inmaculada
    Viu, Maria Melendo
    Iniguez-Romo, Andres
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 180 : 44 - 51
12345